PDL BioPharma, Inc. (PDLI) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
Net income per diluted share (in dollars per share): 0.08
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Net income per diluted share (in dollars per share): 0.08
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
PDL BioPharma, Inc. (NASDAQ: PDLI) reported Q3 EPS of $0.32, $0.02 better than the analyst estimate of $0.30. Revenue for the quarter came in at $85.2 million versus the consensus estimate of $85.03 million.
For earnings history and earnings-related data on PDL BioPharma, Inc. (PDLI) click here.
For earnings history and earnings-related data on PDL BioPharma, Inc. (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
